Up­dat­ed: FDA ap­proves Au­to­lus’ CAR-T cell ther­a­py for ag­gres­sive blood can­cer

US reg­u­la­tors gave the green light to Au­to­lus Ther­a­peu­tics’ cell ther­a­py for adult B cell pre­cur­sor acute lym­phoblas­tic leukemia, or B-ALL, that has re­turned or …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER